Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%

NCT01926496 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

485

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratosis (AK)

Interventions

DRUG: Ingenol Mebutate Gel, 0.015%
DRUG: Imiquimod Cream, 5%

Sponsor

LEO Pharma